1. Home
  2. NCNA vs ZBAI Comparison

NCNA vs ZBAI Comparison

Compare NCNA & ZBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NCNA
  • ZBAI
  • Stock Information
  • Founded
  • NCNA 1997
  • ZBAI 2015
  • Country
  • NCNA United Kingdom
  • ZBAI United States
  • Employees
  • NCNA N/A
  • ZBAI N/A
  • Industry
  • NCNA Biotechnology: Pharmaceutical Preparations
  • ZBAI Professional Services
  • Sector
  • NCNA Health Care
  • ZBAI Consumer Discretionary
  • Exchange
  • NCNA Nasdaq
  • ZBAI Nasdaq
  • Market Cap
  • NCNA 6.6M
  • ZBAI 6.5M
  • IPO Year
  • NCNA 2017
  • ZBAI N/A
  • Fundamental
  • Price
  • NCNA $3.86
  • ZBAI $8.88
  • Analyst Decision
  • NCNA
  • ZBAI
  • Analyst Count
  • NCNA 0
  • ZBAI 0
  • Target Price
  • NCNA N/A
  • ZBAI N/A
  • AVG Volume (30 Days)
  • NCNA 346.4K
  • ZBAI 32.4K
  • Earning Date
  • NCNA 08-20-2025
  • ZBAI 11-12-2025
  • Dividend Yield
  • NCNA N/A
  • ZBAI N/A
  • EPS Growth
  • NCNA N/A
  • ZBAI N/A
  • EPS
  • NCNA N/A
  • ZBAI N/A
  • Revenue
  • NCNA N/A
  • ZBAI $720,000.00
  • Revenue This Year
  • NCNA N/A
  • ZBAI N/A
  • Revenue Next Year
  • NCNA N/A
  • ZBAI N/A
  • P/E Ratio
  • NCNA N/A
  • ZBAI N/A
  • Revenue Growth
  • NCNA N/A
  • ZBAI 44.00
  • 52 Week Low
  • NCNA $2.78
  • ZBAI $4.83
  • 52 Week High
  • NCNA $1,650.00
  • ZBAI $45.00
  • Technical
  • Relative Strength Index (RSI)
  • NCNA 41.45
  • ZBAI 73.91
  • Support Level
  • NCNA $2.82
  • ZBAI $5.65
  • Resistance Level
  • NCNA $3.60
  • ZBAI $7.84
  • Average True Range (ATR)
  • NCNA 0.24
  • ZBAI 0.70
  • MACD
  • NCNA 0.43
  • ZBAI 0.37
  • Stochastic Oscillator
  • NCNA 74.48
  • ZBAI 82.19

About NCNA NuCana plc

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.

About ZBAI ATIF Holdings Limited Ordinary Shares

ATIF Holdings Ltd is a consulting company. It provides financial and advisory services to small and medium-sized enterprises and also to individual customers and families. The firm also offers Pre-IPO's, and Post-IPO's services. It operates in one operating segment which is the consulting service business. It generates the majority of its revenue from the USA.

Share on Social Networks: